top of page
it's where dermatology lives



New study supports low-dose isotretinoin for resistant rosacea
A systematic review published as a short form communication in JAAD International has found evidence that low-dose isotretinoin can be an...
Allan Ryan
Jun 3, 20242 min read


Oral contraceptives may contribute to frontal fibrosing alopecia risk
Findings from a new study suggest that taking oral contraceptives could be linked to frontal fibrosing alopecia (FFA). The study,...
John Evans
May 31, 20242 min read


Onychopapilloma a potential marker for BAP1 tumour predisposition syndrome
New findings suggest the presence of a benign nail abnormality may lead to the diagnosis of a rare inherited disorder that increases the...
John Evans
May 24, 20242 min read


Neuropeptide in blood may lead to targeted treatment for chronic itch
A new study has identified what may be the first biomarker for chronic itch. Published in Drugs in Dermatology, researchers from the...
Allan Ryan
May 6, 20242 min read


U.S. FDA issues counterfeit botulinum toxin alert
The U.S. Food and Drug Administration (FDA) has released an alert to healthcare professionals and consumers that unsafe counterfeit versions
John Evans
May 3, 20242 min read


Identified: Porokeratosis variant caused by silenced gene
“We thus expect that epigenetic causes are hidden not only in these but also in other diseases"
John Evans
Apr 26, 20243 min read
OCT ‘virtual biopsies’ could reduce need for invasive procedures
“This [development] has the potential to transform how we diagnose and monitor concerning skin lesions and diseases in the clinic.”
Allan Ryan
Apr 22, 20242 min read


CDA, Acne and Rosacea Society of Canada release joint statement on benzene from products containing BPO
The Canadian Dermatology Association, in collaboration with the Acne and Rosacea Society of Canada, has issued a joint position...
Allan Ryan
Apr 15, 20241 min read
Featured Posts




bottom of page

